Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 6.94% vs 11.90% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is 15.77% vs 37.60% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 10.48% vs 33.95% in Sep 2024
Interest
Growth in half year ended Sep 2025 is -4.06% vs 96.32% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Indrapr.Medical With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
746.09
764.33
-18.24
-2.39%
Other Operating Income
0.00
1.59
-1.59
-100.00%
Total Operating income
746.09
765.92
-19.83
-2.59%
Raw Material Cost
128.29
203.43
-75.14
-36.94%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
138.53
147.07
-8.54
-5.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
197.34
54.78
142.56
260.24%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
137.47
147.83
-10.36
-7.01%
Total Expenditure (Excl Depreciation)
601.63
553.11
48.52
8.77%
Operating Profit (PBDIT) excl Other Income
144.46
212.81
-68.35
-32.12%
Other Income
14.27
12.08
2.19
18.13%
Operating Profit (PBDIT)
158.73
224.89
-66.16
-29.42%
Interest
3.07
17.91
-14.84
-82.86%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
155.66
206.98
-51.32
-24.79%
Depreciation
21.04
52.71
-31.67
-60.08%
Profit Before Tax
134.62
154.27
-19.65
-12.74%
Tax
33.70
38.19
-4.49
-11.76%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
100.92
116.09
-15.17
-13.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
100.92
116.09
-15.17
-13.07%
Equity Capital
91.67
10.94
80.73
737.93%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
11.01
106.12
-95.11
-89.62%
Diluted Earnings per share
11.01
109.09
-98.08
-89.91%
Operating Profit Margin (Excl OI)
19.36%
27.84%
0.00
-8.48%
Gross Profit Margin
20.86%
27.08%
0.00
-6.22%
PAT Margin
13.53%
15.19%
0.00
-1.66%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 746.09 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 6.94% vs 11.90% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 100.92 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 15.77% vs 37.60% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 144.46 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 10.48% vs 33.95% in Sep 2024
Half Yearly - Interest
Interest 3.07 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -4.06% vs 96.32% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.36%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
